SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Total Expenses

Annual Total Expenses:

$1.68B+$172.74M(+11.43%)
December 31, 2024

Summary

  • As of today, SRPT annual total expenses is $1.68 billion, with the most recent change of +$172.74 million (+11.43%) on December 31, 2024.
  • During the last 3 years, SRPT annual total expenses has risen by +$532.30 million (+46.22%).
  • SRPT annual total expenses is now at all-time high.

Performance

SRPT Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Quarterly Total Expenses:

$579.30M+$165.10M(+39.86%)
September 30, 2025

Summary

  • As of today, SRPT quarterly total expenses is $579.30 million, with the most recent change of +$165.10 million (+39.86%) on September 30, 2025.
  • Over the past year, SRPT quarterly total expenses has increased by +$145.74 million (+33.62%).
  • SRPT quarterly total expenses is now -51.42% below its all-time high of $1.19 billion, reached on March 31, 2025.

Performance

SRPT Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

SRPT Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+11.4%+33.6%
3Y3 Years+46.2%+18.7%
5Y5 Years+86.5%+70.2%

SRPT Total Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+46.2%-51.4%+103.1%
5Y5-Yearat high+86.5%-51.4%+143.9%
All-TimeAll-Timeat high>+9999.0%-51.4%+955.1%

SRPT Total Expenses History

DateAnnualQuarterly
Sep 2025
-
$579.30M(+39.9%)
Jun 2025
-
$414.20M(-65.3%)
Mar 2025
-
$1.19B(+138.8%)
Dec 2024
$1.68B(+11.4%)
$499.36M(+15.2%)
Sep 2024
-
$433.56M(+21.6%)
Jun 2024
-
$356.47M(-5.5%)
Mar 2024
-
$377.35M(+7.5%)
Dec 2023
$1.51B(+2.9%)
$351.13M(-5.8%)
Sep 2023
-
$372.75M(+30.7%)
Jun 2023
-
$285.18M(-63.0%)
Mar 2023
-
$770.25M(+109.5%)
Dec 2022
$1.47B(+27.6%)
$367.67M(-24.7%)
Sep 2022
-
$488.01M(+5.0%)
Jun 2022
-
$464.97M(+47.2%)
Mar 2022
-
$315.86M(-2.3%)
Dec 2021
$1.15B(+4.3%)
$323.44M(+36.2%)
Sep 2021
-
$237.55M(-3.2%)
Jun 2021
-
$245.49M(-21.9%)
Mar 2021
-
$314.18M(-6.1%)
Dec 2020
$1.10B(+22.3%)
$334.45M(-1.8%)
Sep 2020
-
$340.42M(+18.1%)
Jun 2020
-
$288.18M(+119.7%)
Mar 2020
-
$131.17M(-60.9%)
Dec 2019
$903.16M(+40.1%)
$335.82M(+49.0%)
Sep 2019
-
$225.37M(-39.3%)
Jun 2019
-
$371.07M(+126.7%)
Mar 2019
-
$163.65M(-27.4%)
Dec 2018
$644.66M(+116.5%)
$225.31M(+45.5%)
Sep 2018
-
$154.88M(-15.3%)
Jun 2018
-
$182.80M(+82.9%)
Mar 2018
-
$99.97M(+23.0%)
Dec 2017
$297.80M(+10.5%)
$81.28M(-13.2%)
Sep 2017
-
$93.69M(-4.5%)
Jun 2017
-
$98.06M(+244.7%)
Mar 2017
-
-$67.75M(-172.2%)
Dec 2016
$269.60M(+21.8%)
$93.87M(+65.4%)
Sep 2016
-
$56.74M(-8.9%)
Jun 2016
-
$62.30M(+4.2%)
Mar 2016
-
$59.77M(-9.3%)
Dec 2015
$221.44M(+54.3%)
$65.93M(+26.9%)
Sep 2015
-
$51.94M(+24.1%)
Jun 2015
-
$41.85M(-32.0%)
Mar 2015
-
$61.56M(+38.5%)
Dec 2014
$143.55M(+37.4%)
$44.44M(+46.7%)
Sep 2014
-
$30.29M(-16.9%)
Jun 2014
-
$36.46M(+6.1%)
Mar 2014
-
$34.36M(+200.2%)
Dec 2013
$104.50M(+55.9%)
$11.45M(-75.2%)
Sep 2013
-
$46.20M(+110.0%)
Jun 2013
-
$22.00M(-52.7%)
Mar 2013
-
$46.56M(-32.9%)
Dec 2012
$67.03M(-19.2%)
$69.40M(+21.5%)
Sep 2012
-
$57.13M(+1702.7%)
Jun 2012
-
$3.17M(-89.0%)
Mar 2012
-
$28.92M(+92.8%)
Dec 2011
$82.92M
$14.99M(+29.9%)
Sep 2011
-
$11.54M(+12.0%)
Jun 2011
-
$10.31M(-17.3%)
DateAnnualQuarterly
Mar 2011
-
$12.46M(-46.2%)
Dec 2010
$50.35M(+52.2%)
$23.16M(+44.8%)
Sep 2010
-
$15.99M(-22.6%)
Jun 2010
-
$20.65M(+1054.4%)
Mar 2010
-
$1.79M(+10.7%)
Dec 2009
$33.09M(-14.7%)
$1.62M(-88.8%)
Sep 2009
-
$14.44M(-36.1%)
Jun 2009
-
$22.61M(+454.6%)
Mar 2009
-
$4.08M(-38.4%)
Dec 2008
$38.80M(-12.0%)
$6.62M(-40.0%)
Sep 2008
-
$11.03M(+63.8%)
Jun 2008
-
$6.73M(-67.4%)
Mar 2008
-
$20.64M(+121.6%)
Dec 2007
$44.09M(+33.2%)
$9.31M(-6.4%)
Sep 2007
-
$9.95M(-8.6%)
Jun 2007
-
$10.89M(+6.1%)
Mar 2007
-
$10.26M(+22.9%)
Dec 2006
$33.10M(+48.4%)
$8.35M(+33.2%)
Sep 2006
-
$6.26M(-9.5%)
Jun 2006
-
$6.92M(-24.2%)
Mar 2006
-
$9.13M(+52.9%)
Dec 2005
$22.30M(-12.5%)
$5.97M(+20.0%)
Sep 2005
-
$4.97M(+0.0%)
Jun 2005
-
$4.97M(-10.3%)
Mar 2005
-
$5.54M(+5.1%)
Dec 2004
$25.47M(+28.4%)
$5.28M(+3.1%)
Sep 2004
-
$5.12M(-28.8%)
Jun 2004
-
$7.18M(-5.9%)
Mar 2004
-
$7.63M(+136.2%)
Dec 2003
$19.84M(-24.2%)
$3.23M(-35.6%)
Sep 2003
-
$5.02M(+37.1%)
Jun 2003
-
$3.66M(-0.4%)
Mar 2003
-
$3.68M(-11.7%)
Dec 2002
$26.18M(+62.5%)
$4.16M(-42.8%)
Sep 2002
-
$7.28M(-31.9%)
Jun 2002
-
$10.70M(+32.8%)
Mar 2002
-
$8.05M(+64.4%)
Dec 2001
$16.11M(+39.6%)
$4.90M(-69.2%)
Sep 2001
-
$15.90M(+337.7%)
Jun 2001
-
$3.63M(+13.7%)
Mar 2001
-
$3.19M(+5.3%)
Dec 2000
$11.54M(+37.4%)
$3.03M(+27.7%)
Sep 2000
-
$2.37M(-16.9%)
Jun 2000
-
$2.86M(+25.8%)
Mar 2000
-
$2.27M(>+9900.0%)
Dec 1999
$8.40M(+6.3%)
$9200.00(-99.6%)
Sep 1999
-
$2.21M(+10.6%)
Jun 1999
-
$2.00M(+14.6%)
Mar 1999
-
$1.74M(+1583.0%)
Dec 1998
$7.90M(+97.5%)
$103.60K(-99.5%)
Sep 1998
-
$21.26M(+1176.6%)
Jun 1998
-
$1.67M(+16.4%)
Mar 1998
-
$1.43M(+43.0%)
Dec 1997
$4.00M(+73.9%)
$1.00M(0.0%)
Sep 1997
-
$1.00M(-23.1%)
Jun 1997
-
$1.30M(+85.7%)
Mar 1997
-
$700.00K
Dec 1996
$2.30M
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual total expenses?
  • What is the all-time high annual total expenses for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual total expenses year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly total expenses?
  • What is the all-time high quarterly total expenses for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly total expenses year-on-year change?

What is Sarepta Therapeutics, Inc. annual total expenses?

The current annual total expenses of SRPT is $1.68B

What is the all-time high annual total expenses for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual total expenses is $1.68B

What is Sarepta Therapeutics, Inc. annual total expenses year-on-year change?

Over the past year, SRPT annual total expenses has changed by +$172.74M (+11.43%)

What is Sarepta Therapeutics, Inc. quarterly total expenses?

The current quarterly total expenses of SRPT is $579.30M

What is the all-time high quarterly total expenses for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly total expenses is $1.19B

What is Sarepta Therapeutics, Inc. quarterly total expenses year-on-year change?

Over the past year, SRPT quarterly total expenses has changed by +$145.74M (+33.62%)
On this page